Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Bottom-Up

Japan Eyewear Holdings   / Equity Bottom-Up

<ul>
<li>
<a href="https://www.smartkarma.com/entities/japan-eyewear-holdings-co-ltd" target="_blank" data-smartkarma-citation="entities:40217:1" rel="noopener">Japan Eyewear Holdings (5889 JP)</a> shares are moving from the Standard Market to the Prime Market of the Tokyo Stock Exchange, thereby enhancing visibility and liquidity.</li>
<li>The company has been showing consistently strong financial performance, driven by continuous recovery in inbound tourists. Overseas sales are also gaining traction.</li>
<li>For FY30, JEH targets revenue of ¥28B, representing five-year CAGR of 10%. JEH aims to achieve operating profit of ¥10B in FY30, a CAGR of 13% during FY25–30.</li>
</ul>



Japan Eyewear Holdings (5889 JP) shares are moving from the Standard Market to the Prime Market of the Tokyo Stock Exchange, thereby enhancing visibility and liquidity.
The company has been showing consistently strong financial performance, driven by continuous recovery in inbound tourists. Overseas sales are also gaining traction.
For FY30, JEH targets revenue of ¥28B, representing five-year CAGR of 10%. JEH aims to achieve operating profit of ¥10B in FY30, a CAGR of 13% during FY25–30.


Japan Eyewear (5889 JP): Corporate Governance Issue Seems Easing; Inbound Demand to Drive Growth